Condition: Healthy Volunteer · Sponsor: Mirador Therapeutics, Inc.
First-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple doses of MT-201 in healthy participants.
This description comes directly from the study's public registry record.
Toll-Free Number · 844-206-4980 · clinicaltrials@miradortx.com
Always discuss trial participation with your own doctor first.
| Mirador Clinical Department, San Diego, California 92121 | San Diego, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07219368